­

From the Desk of the President – Update on Stem Cell Clinics

By David Crouse, PhD In the fall of 2019 edition of this newsletter, I provided an update on the problems with “direct-to-consumer marketing” of stem ...

By |May 18th, 2021|

New FDA Consumer Alert on Stem Cell and Exosome Products

The US Food and Drug Administration (FDA) has authority to regulate regenerative medicine products, including stem cell products and exosome products. There is a lot ...

By |July 28th, 2020|
  • Kris Boesen, CIRM spinal cord injury clinical trial patient.

Young man with spinal cord injury regains use of hands and arms after stem cell therapy

Hope is such a fragile thing. We cling to it in bad times. It offers us a sense that we can bear whatever hardships we ...

By |September 14th, 2016|